Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis. 2019

R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester NIHR Biomedical Research Centre, University of Manchester, Manchester, UK.

UI MeSH Term Description Entries
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D005650 Fumarates Compounds based on fumaric acid. Fumarate,Fumaric Acid Ester,Fumaric Acid Esters,Fumarate Esters,Acid Ester, Fumaric,Acid Esters, Fumaric,Ester, Fumaric Acid,Esters, Fumarate,Esters, Fumaric Acid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069462 Dimethyl Fumarate A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS. 2-butenedioic acid, (2E)-, dimethyl ester,BG 00012,BG 12 compound,BG-00012,BG-12 compound,BG00012,BG12 compound,Dimethylfumarate,FAG 201,FAG-201,FAG201,Fumaderm,Tecfidera,00012, BG,12 compound, BG,201, FAG,Fumarate, Dimethyl,compound, BG 12,compound, BG12

Related Publications

R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
September 2019, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
July 2003, The British journal of dermatology,
R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
January 1990, Dermatologica,
R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
August 2011, Clinical and experimental dermatology,
R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
October 2010, The clinical respiratory journal,
R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
May 1984, Zeitschrift fur Hautkrankheiten,
R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
March 2006, The British journal of dermatology,
R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
May 1974, Deutsche medizinische Wochenschrift (1946),
R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
May 2019, Journal of the European Academy of Dermatology and Venereology : JEADV,
R B Warren, and J N W Barker, and P Van de Kerkhof, and K Reich, and U Mrowietz
September 1999, The British journal of dermatology,
Copied contents to your clipboard!